News Releases
Mar 19 2002
Avid Bioservices Announces Manufacturing Supply Agreement With Inhibitex for the Production of Therapeutic Monoclonal Antibodies
Mar 18 2002
Peregrine Announces Quarterly Conference Call
Mar 13 2002
Avid Bioservices Announces Manufacturing Supply Agreement for the Production of a Therapeutic Monoclonal Antibody Intended for Phase III Clinical Trials
Mar 6 2002
Avid Bioservices Enters Into a Manufacturing and Supply Agreement With Seradyn
Mar 4 2002
Peregrine Announces Grant of Patent for New Class of Vascular Targeting Agents
Feb 28 2002
Peregrine and OXiGENE Conclude Arcus Therapeutics LLC Joint Venture; Companies Reacquire Full Rights to Respective Vascular Targeting Technologies
Feb 4 2002
Peregrine Pharmaceuticals Announces $2.2 Million Investment From Institutional Investors
Jan 29 2002
Peregrine Pharmaceuticals Announces Grant of Patent for New Anti-Cancer Antibodies
Jan 8 2002
Peregrine Pharmaceuticals Announces Formation of Contract Manufacturing Subsidiary Avid Bioservices Inc.
Dec 20 2001
Peregrine Pharmaceuticals Announces the Initiation of Human Antibody Generation Against Two Additional Antigen Targets With Xenerex Biosciences